These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27105042)

  • 1. Pharmacological Modulation of Calcium Homeostasis in Familial Dilated Cardiomyopathy: An In Vitro Analysis From an RBM20 Patient-Derived iPSC Model.
    Wyles SP; Hrstka SC; Reyes S; Terzic A; Olson TM; Nelson TJ
    Clin Transl Sci; 2016 Jun; 9(3):158-67. PubMed ID: 27105042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.
    Wyles SP; Li X; Hrstka SC; Reyes S; Oommen S; Beraldi R; Edwards J; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2016 Jan; 25(2):254-65. PubMed ID: 26604136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
    J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Regulation of Phosphodiesterases 2A and 3A Underlies Compromised β-Adrenergic Signaling in an iPSC Model of Dilated Cardiomyopathy.
    Wu H; Lee J; Vincent LG; Wang Q; Gu M; Lan F; Churko JM; Sallam KI; Matsa E; Sharma A; Gold JD; Engler AJ; Xiang YK; Bers DM; Wu JC
    Cell Stem Cell; 2015 Jul; 17(1):89-100. PubMed ID: 26095046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An abnormal TRPV4-related cytosolic Ca
    Lu J; Lee YK; Ran X; Lai WH; Li RA; Keung W; Tse K; Tse HF; Yao X
    Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2964-2972. PubMed ID: 28754452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of
    Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
    Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
    Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
    Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
    Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rbm20-deficient cardiogenesis reveals early disruption of RNA processing and sarcomere remodeling establishing a developmental etiology for dilated cardiomyopathy.
    Beraldi R; Li X; Martinez Fernandez A; Reyes S; Secreto F; Terzic A; Olson TM; Nelson TJ
    Hum Mol Genet; 2014 Jul; 23(14):3779-91. PubMed ID: 24584570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin destabilization impairs sarcomere-cytoskeleton interactions in iPSC-derived cardiomyocytes from dilated cardiomyopathy patients.
    Dai Y; Amenov A; Ignatyeva N; Koschinski A; Xu H; Soong PL; Tiburcy M; Linke WA; Zaccolo M; Hasenfuss G; Zimmermann WH; Ebert A
    Sci Rep; 2020 Jan; 10(1):209. PubMed ID: 31937807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy.
    Briganti F; Sun H; Wei W; Wu J; Zhu C; Liss M; Karakikes I; Rego S; Cipriano A; Snyder M; Meder B; Xu Z; Millat G; Gotthardt M; Mercola M; Steinmetz LM
    Cell Rep; 2020 Sep; 32(10):108117. PubMed ID: 32905764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating
    Shemer Y; Mekies LN; Ben Jehuda R; Baskin P; Shulman R; Eisen B; Regev D; Arbustini E; Gerull B; Gherghiceanu M; Gottlieb E; Arad M; Binah O
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360639
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional and transcriptomic insights into pathogenesis of R9C phospholamban mutation using human induced pluripotent stem cell-derived cardiomyocytes.
    Ceholski DK; Turnbull IC; Kong CW; Koplev S; Mayourian J; Gorski PA; Stillitano F; Skodras AA; Nonnenmacher M; Cohen N; Björkegren JLM; Stroik DR; Cornea RL; Thomas DD; Li RA; Costa KD; Hajjar RJ
    J Mol Cell Cardiol; 2018 Jun; 119():147-154. PubMed ID: 29752948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Electrical Stimulation Increased Cardiac Apoptosis Through Disturbance of Calcium Homeostasis and Mitochondrial Dysfunction in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Geng L; Wang Z; Cui C; Zhu Y; Shi J; Wang J; Chen M
    Cell Physiol Biochem; 2018; 47(3):1167-1180. PubMed ID: 29913448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
    Perea-Gil I; Seeger T; Bruyneel AAN; Termglinchan V; Monte E; Lim EW; Vadgama N; Furihata T; Gavidia AA; Arthur Ataam J; Bharucha N; Martinez-Amador N; Ameen M; Nair P; Serrano R; Kaur B; Feyen DAM; Diecke S; Snyder MP; Metallo CM; Mercola M; Karakikes I
    Eur Heart J; 2022 Sep; 43(36):3477-3489. PubMed ID: 35728000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of circular RNAs with host gene-independent expression in human model systems for cardiac differentiation and disease.
    Siede D; Rapti K; Gorska AA; Katus HA; Altmüller J; Boeckel JN; Meder B; Maack C; Völkers M; Müller OJ; Backs J; Dieterich C
    J Mol Cell Cardiol; 2017 Aug; 109():48-56. PubMed ID: 28676412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.
    Feyen DAM; McKeithan WL; Bruyneel AAN; Spiering S; Hörmann L; Ulmer B; Zhang H; Briganti F; Schweizer M; Hegyi B; Liao Z; Pölönen RP; Ginsburg KS; Lam CK; Serrano R; Wahlquist C; Kreymerman A; Vu M; Amatya PL; Behrens CS; Ranjbarvaziri S; Maas RGC; Greenhaw M; Bernstein D; Wu JC; Bers DM; Eschenhagen T; Metallo CM; Mercola M
    Cell Rep; 2020 Jul; 32(3):107925. PubMed ID: 32697997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
    Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
    Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impacts of DCM-linked gating pore currents on the electrophysiological characteristics of hiPSC-CM monolayers.
    Djemai M; Jalouli M; Chahine M
    Biochem Biophys Res Commun; 2024 Sep; 723():150175. PubMed ID: 38820625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.
    Lin B; Li Y; Han L; Kaplan AD; Ao Y; Kalra S; Bett GC; Rasmusson RL; Denning C; Yang L
    Dis Model Mech; 2015 May; 8(5):457-66. PubMed ID: 25791035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.